 McKesson Corporation, AmerisourceBergen, and Cardinal Health spent $13 million lobbying in support of the bill.When Joseph Rannazzisi, the chief of the Drug Enforcement Administration (DEA)'s Office of Diversion Control, strongly criticized the bill, Marino and his cosponsor Marsha Blackburn demanded that the drug diversion enforcer be investigated by the United States Department of Justice Office of the Inspector General.Nothing came of the investigation but Rannazzisi was removed from his position in August and retired in October 2015.